Joanna Breitstein, Executive Editor

A look at some of the court cases that could actually change the pharma playing field

Novartis' Paul Herrling talks about how Big Pharma can learn from nonprofit R&D and collaborate to get an edge on the drug safety problem.

Despite more programs to increase diversity, a new study shows that women are gaining no ground in climbing pharma's corporate ladder.

Avandia continues on its sales slide. Generic metformin reigns supreme, while Actos and Januvia battle for second place.